Item 2.02 Results of Operation and Financial Condition.

On March 31, 2023, Emmaus Life Sciences, Inc. issued a press release announcing the results of operations and financial condition for the fiscal year ended December 31, 2022. A copy of the press release is included as Exhibit 99.1 to this Current Report and incorporated herein by reference.

The information included in this Item 2.02 and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 ("Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits





(d) Exhibits

See the accompanying Index to Exhibits, which information is incorporated herein by reference.





                                       1

© Edgar Online, source Glimpses